Skip to navigation Skip to main content

Search...

Breast
CML
Gastrointestinal
GYN
Lung
Multiple Myeloma
Prostate
RCC
Skin
More
- More
  Bladder Cancer
  
  Bone Cancer
  
  Brain Cancer
  
  Chronic Lymphocytic Leukemia
  Endocrine Cancer
  
  General Medicine
  
  General Oncology
  
  Head and Neck Cancer
  
  Hematologic Cancers
  Lymphoma
  
  Pancreatic Cancer
  
  Pediatric Cancer
  
  Practice Management
  Sarcoma
  
  Supportive Care
  
  Urologic Cancers

Headlines
Drugs
Conferences
Cancer Management
Clinical Resources
Tools
Multimedia
CME
Jobs

Get the App
Submit Cases

ELAHERE Rx

Share by Email
Print

Generic Name & Formulations:

Mirvetuximab soravtansine-gynx 5mg/mL; soln for IV infusion after dilution; preservative-free.

Company:

ImmunoGen, Inc.

Gynecologic Cancers

Gynecologic Cancers:

Loading...
Loading...

Continuing Medical Education (CME/CE) Courses
Show More

CancerTherapyAdvisor.com is a free online resource that offers oncology healthcare professionals a comprehensive knowledge base of practical oncology information and clinical tools to assist in making the right decisions for their patients.

Our mission is to provide practice-focused clinical and drug information that is reflective of current and emerging principles of care that will help to inform oncology decisions.

Resources

User Center
- About Us
- Advertise
- Contact Us
- Staff

Other Haymarket Medical Websites

Copyright © 2023 Haymarket Media, Inc. All Rights Reserved
This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.
Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms & Conditions.

Loading...

Loading...